Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Braze (BRZE) Stock on December 10, 2025: Q3 Earnings, AI Deals and a Wave of Analyst Upgrades

Braze (BRZE) Stock on December 10, 2025: Q3 Earnings, AI Deals and a Wave of Analyst Upgrades

December 10, 2025 – Braze, Inc., the customer‑engagement software provider, is back in focus after delivering strong fiscal third‑quarter 2026 results, lifting full‑year guidance and triggering a rush of bullish analyst calls. The stock last closed regular trading at $30.65, up about 2.1% on the day, leaving shares roughly 27% lower year to date and about 37% below their 52‑week high of $48.33.Finviz+1
AeroVironment (AVAV) Stock on December 10, 2025: Record Q2 Revenue, $874M Army Deal and Fresh Wall Street Targets

AeroVironment (AVAV) Stock on December 10, 2025: Record Q2 Revenue, $874M Army Deal and Fresh Wall Street Targets

AeroVironment, Inc., the U.S. drone and defense technology specialist, is in focus on 10 December 2025 after delivering record fiscal Q2 2026 revenue, raising its full‑year sales outlook and securing an $874 million U.S. Army contract, even as the share price trades far below its October peak. FinancialContent+4Business Wire+4Avinc+4
DocuSign (DOCU) Stock: Earnings Beat, AI Push and Analyst Forecasts as of December 10, 2025

DocuSign (DOCU) Stock: Earnings Beat, AI Push and Analyst Forecasts as of December 10, 2025

DocuSign, Inc. is back in the spotlight after a strong fiscal Q3 2026 earnings beat, a fresh AI investment in Europe, and a sharp share-price swing driven by “conservative” guidance. As of the last close on December 9, 2025, DocuSign stock finished at $69.39, up just over 5% on the day but still down roughly 23% year to date and about 35% below its high from last December. StockAnalysis+2MarketScreener+2
Cypherpunk Technologies (CYPH) Stock: Zcash Treasury Pivot, Winklevoss Backing and 2026 Forecast Explained

Cypherpunk Technologies (CYPH) Stock: Zcash Treasury Pivot, Winklevoss Backing and 2026 Forecast Explained

Cypherpunk Technologies Inc. has stormed into the spotlight after a radical pivot from small‑cap biotech to what is effectively a listed Zcash treasury vehicle backed by the Winklevoss twins. The stock has been halted, squeezed, sold by insiders, loved by day‑traders and treated with caution by Wall Street — all in under a month.
1-800-FLOWERS.COM (FLWS) Stock Jumps 30% on AI-Focused CIO Hire: Latest News, Debt Risk and 2026 Forecast

1-800-FLOWERS.COM (FLWS) Stock Jumps 30% on AI-Focused CIO Hire: Latest News, Debt Risk and 2026 Forecast

1-800-FLOWERS.COM, Inc. just went from sleepy micro-cap to headline-grabber. After the company announced a new Chief Information Officer with a mandate to accelerate artificial intelligence and digital commerce, the stock exploded higher, putting it squarely on traders’ radar even as its balance sheet and earnings remain under serious pressure. Stock Titan+1
CVS Health (CVS) Stock Soars in 2025 on New Guidance, AI Push and Clinic Reset – Is the Turnaround Finally Real?

CVS Health (CVS) Stock Soars in 2025 on New Guidance, AI Push and Clinic Reset – Is the Turnaround Finally Real?

New York / Hartford – December 10, 2025 – CVS Health Corporation is back in Wall Street’s good graces. After a bruising 2024, the stock has staged a powerful rebound in 2025 as management raised its 2025–2026 profit outlook, unveiled an AI‑native engagement platform, and tightened its primary‑care strategy.
BitMine Immersion Technologies Stock (BMNR) on December 10, 2025: Ethereum Mega‑Treasury, 50B‑Share Plan and High‑Risk 2026 Outlook

BitMine Immersion Technologies Stock (BMNR) on December 10, 2025: Ethereum Mega‑Treasury, 50B‑Share Plan and High‑Risk 2026 Outlook

BitMine Immersion Technologies has turned into one of the loudest tickers in U.S. markets in late 2025. It’s no longer just a Bitcoin miner with immersion‑cooling hardware; it’s effectively an Ethereum super‑treasury with a public listing, options market, and even its own leveraged ETF ecosystem. StockAnalysis+1
10 December 2025
Biodexa Pharmaceuticals (NASDAQ: BDRX) Stock on December 10, 2025: Violent Rally, Phase 3 FAP Progress and What 2026 Might Hold

Biodexa Pharmaceuticals (NASDAQ: BDRX) Stock on December 10, 2025: Violent Rally, Phase 3 FAP Progress and What 2026 Might Hold

Biodexa Pharmaceuticals plc has turned into one of the most volatile biotech tickers of late 2025. After a sharp multi‑day surge driven by retail trading interest and momentum headlines, the stock has whipsawed back down, even as the company advances a pivotal Phase 3 trial in a rare inherited cancer syndrome and lines up multiple new financing options. StockInvest+2MarketWatch+2
Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax Société Anonyme is back in the spotlight on December 10, 2025, after its share price spiked again on fresh takeover speculation involving U.S. pharma giant Eli Lilly. The move caps an extraordinary year in which the French biotech has transformed from a relatively obscure name into a multibillion‑euro inflammatory bowel disease contender.Reuters+1
Biggest Stock Losers Today in the U.S. (Dec. 10, 2025): DYN, SLM, KTB, WAY and More Slide as Fed Decision Looms

Biggest Stock Losers Today in the U.S. (Dec. 10, 2025): DYN, SLM, KTB, WAY and More Slide as Fed Decision Looms

U.S. stocks are trading in a holding pattern on Wednesday, December 10, 2025, as Wall Street waits for the Federal Reserve’s final interest‑rate decision of the year. Index moves are modest, but beneath the surface a cluster of mid‑cap names is posting double‑digit percentage declines, led by Dyne Therapeutics, SLM Corp, Kontoor Brands and Waystar Holding. Investing.com+1
1 513 514 515 516 517 608

Google Preferred Source

TS2 TECH • AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY ON WEAKNESS

Visa

NYSE: V 93 / 100

Visa delivered more than just a headline beat this quarter, with spending, payment volume, cross-border volume, and processed transactions each rising by double digits.…

#2 BUY

Hubbell

NYSE: HUBB 92 / 100

Hubbell boosted its sales and profit outlook following strong double-digit organic growth. Although shares dipped 2.8% on Tuesday, the company’s operating performance is on…

#3 BUY ON PULLBACK

Xylem

NYSE: XYL 90 / 100

Xylem reported $3.1 billion in orders last quarter, providing clearer visibility than the modest 2% revenue growth indicates. Demand for water treatment is rising…

#4 ACCUMULATE

Ford

NYSE: F 86 / 100

Ford’s updated cash forecast stands out compared to its market capitalization. Strong truck pricing, product mix, and cost discipline supported this quarter. However, the…

#5 TACTICAL BUY

SoFi

NASDAQ: SOFI 82 / 100

SoFi boosted its revenue outlook following record growth in members, loan originations, and profit. Lending remains robust, but technology platform revenue dropped 23% year-over-year.…

View full portfolio
Editorial model selection. Not personalised advice.